Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Jeff Katke
Individual Investor

Jeff Katke

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Current Board & Advisor Roles 2
  • Investor Type 
    obfuscation
  • Investor Stage 
    obfuscation
Jeff Katke was the Founder and CEO of Metagenics. Jeff Katke attended the University of Wisconsin-Madison.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Jeff Katke invested in KinDex Pharmaceuticals on
obfuscation
. This investment - Series A - KinDex Pharmaceuticals - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
KinDex Pharmaceuticals Logo
KinDex Pharmaceuticals
—
Series A - KinDex Pharmaceuticals Logo
Series A - KinDex Pharmaceuticals
obfuscation

Jobs

Edit Jobs Section
Number of Past Jobs 1
Jeff Katke has had 1 past job as the Founder & CEO at Metagenics.
Organization Name  
Title At Company  
Start Date  
End Date  
Metagenics Logo
Metagenics
Founder & CEO19832010

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 2
Jeff Katke holds 2 board and advisor roles as Member, Board of Directors at KinDex Pharmaceuticals and Board Member at Avistone.

Education

Edit Education Section
Jeff Katke studied at University of Wisconsin-Madison.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Mar 9, 2015
KinDex Pharmaceuticals raised
obfuscation
from Jeff Katke and 2 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b4ae374 1)
|